Rankings
▼
Calendar
RMD Q3 2025 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
Q3 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$1.3B
+7.9% YoY
Gross Profit
$766M
59.3% margin
Operating Income
$426M
33.0% margin
Net Income
$365M
28.3% margin
EPS (Diluted)
$2.48
QoQ Revenue Growth
+0.8%
Cash Flow
Operating Cash Flow
$579M
Free Cash Flow
$555M
Stock-Based Comp.
$24M
Balance Sheet
Total Assets
$7.6B
Total Liabilities
$2.0B
Stockholders' Equity
$5.5B
Cash & Equivalents
$933M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.2B
+7.9%
Gross Profit
$766M
$682M
+12.4%
Operating Income
$426M
$375M
+13.8%
Net Income
$365M
$300M
+21.5%
← FY 2025
All Quarters
Q4 2025 →